APA (7th ed.) Citation

C, A., C, O., MS, F., G, B., A, C., & I, C. (2026). Body composition assessment for risk stratification of hepatic steatosis in patients with type 2 diabetes and MASLD undergoing osteoporosis screening. Frontiers in endocrinology, 17, 1901793. https://doi.org/10.3389/fendo.2026.1901793

Chicago Style (17th ed.) Citation

C, Asero, Oliveri C, Franzè MS, Basile G, Catalano A, and Cacciola I. "Body Composition Assessment for Risk Stratification of Hepatic Steatosis in Patients with Type 2 Diabetes and MASLD Undergoing Osteoporosis Screening." Frontiers in Endocrinology 17 (2026): 1901793. https://doi.org/10.3389/fendo.2026.1901793.

MLA (9th ed.) Citation

C, Asero, et al. "Body Composition Assessment for Risk Stratification of Hepatic Steatosis in Patients with Type 2 Diabetes and MASLD Undergoing Osteoporosis Screening." Frontiers in Endocrinology, vol. 17, 2026, p. 1901793, https://doi.org/10.3389/fendo.2026.1901793.